February 17, 2017 Bruce Goldberg, MD, PhD

Slides:



Advertisements
Similar presentations
Copyright © 2001 College of American Pathologists SNOMED CT Clinical Content SNOMED CT contains highly detailed clinical vocabulary covering a broad range.
Advertisements

Catalina Martínez-Costa, Stefan Schulz: Ontology-based reinterpretation of the SNOMED CT context model Ontology-based reinterpretation of the SNOMED CT.
Ontologies - Design principles Cartic Ramakrishnan LSDIS Lab University of Georgia.
Summary Issues and Suggestions Workshop on The Future of the UMLS Semantic Network NLM, April 8, 2005 Olivier Bodenreider Lister Hill National Center for.
Gergely Héja - SMCS2006 Copyright Notice Usage of semanticHEALTH public presentations Each slide is copied 1 exactly as it is presented by the.
Recheck Examinations and Results Of course it’s hard. That’s what makes it difficult.
Biomedical Informatics Some Observations on Clinical Data Representation in EHRs Christopher G. Chute, MD DrPH, Mayo Clinic Chair, ICD11 Revision, World.
Fundamentals, Design, and Implementation, 9/e COS 346 Day 2.
Ontology-based Convergence of Medical Terminologies: SNOMED CT and ICD-11 Institute for Medical Informatics, Statistics and Documentation, Medical University.
Concept Model for observables, investigations, and observation results For the IHTSDO Observables Project Group and LOINC Coordination Project Revision.
SNOMED CT's Condition / Situation approach related to OGMS Stefan Schulz Medical University of Graz (Austria) ICBO 2013 Montreal OGMS Meeting.
SNOMED CT – Distributed Content Management Stefan Schulz Content Committee April 2, 2009.
Scalable representations of diseases in biomedical ontologies and in SNOMED CT Stefan Schulz Institute of Medical Biometry und Medical Informatics University.
Overview, Benefits and how to approach Implementing - Robyn Richards (NEHTA)
WHO – IHTSDO: SNOMED CT – ICD-11 coordination: Conditions vs. Situations Stefan Schulz IHTSDO conference Copenhagen, Apr 24, 2012.
The ICPS: A taxonomy, a classification, an ontology or an information model? Stefan SCHULZ IMBI, University Medical Center, Freiburg, Germany.
Scalable representations of diseases in biomedical ontologies Stefan Schulz, Djamila Raufie, Martin Boeker Institute of Medical Biometry und Medical Informatics.
The Guilty, the Innocent, and the SNOMED Shuffle Attributes in transition.
Some Thoughts to Consider 8 How difficult is it to get a group of people, or a group of companies, or a group of nations to agree on a particular ontology?
IHTSDO Editorial Advisory Group James T. Case Head of Terminology.
© University of Manchester Creative Commons Attribution-NonCommercial 3.0 unported 3.0 license Lexically Suggest, Logically Define: QA of Qualifiers &
OGMS Proposals Alexander P. Cox 2013 ICBO Meeting Montreal, Canada.
SNOMED Core Structures NAHLN January 2005 Las Vegas, NV.
Detection of underspecifications in SNOMED CT concept definitions using language processing 1 Federal Technical University of Paraná (UTFPR), Curitiba,
Nursing Occupations Proposed by: Cynthia Lundberg, BSN Judith Warren, PhD, RN.
Editorial Advisory Group IHTSDO Business Meeting London April 2016 James T. Case Head of Terminology.
Substances Redesign Project update for Content Committee February 11, 2015.
Microorganism Name changes IHTSDO Business Meetings Content Advisory Group April 2016 London, England.
A Proposed Approach to Binding SNOMED CT to HL7 FHIR Dr Linda Bird Senior Implementation Specialist.
S. aureus subtypes based on Methicillin resistance
Representation of Hypersensitivity and Allergy in SNOMED CT
SNOMED Core Structures RF2
David Sperzel, MD, MS August-September 2016
Knowledge Representation Techniques
Representation of Hypersensitivity, Allergy and adverse reactions in SNOMED CT Bruce Goldberg, MD, PhD.
Representation of Hypersensitivity and Allergy in SNOMED CT
David Sperzel, MD, MS August-September 2016
Representation of Hypersensitivity and Allergy in SNOMED CT
SNOMED CT’s RF2: Werner CEUSTERS1 , MD
(existing FSN – hierarchy designator omitted) (proposed term)
Addition of during, during AND/OR after to associated with role hierarchy Original goal of project was to develop model for intraoperative complications.
Scope The scope of this test is to make a preliminary assessment of the fitness of the Draft Observables and Investigation Model (Observables model)
Update on ongoing issues with ECE
Original model Disorder to allergic reaction Allergic state
ece 627 intelligent web: ontology and beyond
Statistical Approaches to Support Device Innovation- FDA View
CIMI Semantics Roundup
Observable entities and Clinical findings
Drug and Substance Project Update
Representing Dispositions
Drug and Substance Project Update
Observable entities and Clinical findings
Allergy Topics.
Complications and sequelae update
Hypersensitivity dispositions as clinical findings
Clinical Assessment Instruments and the LOINC/SNOMED CT Relationship
Device complications.
Experiential education Review
Harmonizing SNOMED CT with BioTopLite
Luciana Kase Tanno, MD, PhD, Moises A
Condition Resource - Overview
ece 627 intelligent web: ontology and beyond
Stefan SCHULZ IMBI, University Medical Center, Freiburg, Germany
Allergy Intolerance Resource – Model Meaning
Potentially Preventable Readmissions
Animating the reference terminology – showing classifiers at work
Semantic Nets and Frames
Potentially Preventable Readmissions
Adverse Event Analysis
BFO meets critics Workshop organised by Barry Smith
Presentation transcript:

February 17, 2017 Bruce Goldberg, MD, PhD ECE update to EAG February 17, 2017 Bruce Goldberg, MD, PhD

Modelling of Complications & Sequela

DEFINITIONS Complication = a disorder caused by another disorder, procedure or event. Sequela = a disorder that follows another disorder, procedure or event and where a causal relationship is specified, it may also be considered a kind of complication.

Issues Based on the definition of a complication provided on the previous slide, all combined disorders and disorders combined with procedures and events for which a causal relationship exists should considered to be kinds of complications. Based on the definition of a complication provided on the previous slide, all combined disorders and disorders combined with procedures and events for which a temporal relationship of following exists with or without a causal relationship should considered to be kinds of sequelae. If a causal relationship is also present the sequela is also a kind of complication An exception to the above are surgical sequela which are considered an anticipated after effect of surgery and are not considered by surgeons to be surgical complications. Likewise surgeons do not consider postoperative complications to be surgical sequelae.

Complications and sequelae are of three types where: The cause is specified. Only a temporal relationship to an associated entity is specified. Both a cause and a temporal relationship to the cause is specified. Type Example Relationship   Disorder<Disorder Disorder<Procedure Specified cause 116225000 Complication of injury (disorder) 47724003 Complication of injection (disorder) DUE_TO Temporal only 403216007 Sweet's disease following infection (disorder) *22247000 Dehiscence of surgical wound (disorder) AFTER Causal + temporal 236427002 Post-traumatic acute tubular necrosis (disorder) SCTID: 73781000 Late radiation dermatitis (disorder) DUE_TO & AFTER

ASSIGNING PARENTS Concepts modeled with DUE_TO have an additional IS_A relationship to Complication (disorder) SCTID: 116223007 Concepts modeled with AFTER have an additional IS_A relationship to Sequela (disorder) SCTID: 362977000 Concepts modeled with both DUE_TO & AFTER have an additional IS_A relationship to Complication (disorder) SCTID: 116223007 & Sequela (disorder) SCTID: 362977000 COMPLICATION DUE_TO & AFTER SEQUELA

Tips The first and third types of complication are often identified by the sematic pattern, complication of… for which “of” implies “due to”. [A number of SCT concepts classified as Sequela e.g. 19357001 | Late effects of trachoma (disorder) should be re-classified as DUE_TO & AFTER] A combined disorder or disorder combined with a procedure with a causal relationship between the two is a kind of complication. Some concepts/FSNs may explicitly state ‘complication’ or ‘sequela’ and these should be assigned with an IS_A relationship to Complication (disorder) SCTID: 116223007 or Sequela (disorder) SCTID: 362977000 unless their modeling suggests they should be modeled with both DUE_TO and AFTER. Concepts that are modeled only with DUE_TO (and thus a ‘complication’) are sometimes where the temporal relationship cannot be ascertained with certainty and could be during and/or after. An anticipated after effect of surgery should not be considered to be a surgical complication and thus should be assigned sequela but not complication as a parent. A postoperative complication should not be considered to be a surgical sequela and thus should be assigned complication but not sequela as a parent.

Alternate approach Eliminate the use of complication and sequela in FSNs and model all content using causal and or temporal relationships with FSNs reflecting the ECE naming conventions for combined disorders and disorders with procedures. Complication and sequela can be used as synonyms or perhaps as preferred terms as required.

Review of SNOMED CT models for representing allergic conditions

Background From a historical perspective, allergic conditions were initially represented in SNOMED CT as three partially related hierarchies of Disorder due to allergic reaction, Allergy (modeled using has definitional manifestation = allergic reaction) and allergic reaction. The first major revision of allergy content was accomplished in 2006 as an attempt to harmonize this area with the WAO/ EAACI nomenclature of allergic disease which specifies a broad domain of hypersensitivity while emphasizing the distinction between allergy (immune hypersensitivity) and non-immunologic hypersensitivity (pseudoallergy). Hypersensitivity disorder was created as a parent of the 3 allergy hierarchies as well as a pseudoallergy hierarchy. A decision was made to redefine the top-level hierarchies using pathological processes (hypersensitivity process, allergic process, pseudoallergic process) analogous to the method used to define the similar autoimmune disease.

Evolution of allergy models After exploring several options, it was decided to adopt the model described by Schultz et. Al. which conflates clinical disorders as conditions with represent either pathological dispositions (propensities), pathological processes (reactions) or pathological structures[1]. Pathological structure was felt to not be applicable to allergy. Schultz’s model also allows for the uncertainty of interpreting some clinical disorders as dispositions and processes. The wording of existing FSNs implies the intended meaning of the allergy concepts as Illustrated below: FSN format Interpretation Allergy (to X), (X) allergy Pathological disposition Allergic reaction (to X) Pathological process Allergic disease (due to X) e.g. allergic rhinitis due to pollen Pathological disposition or process [1]Schulz, S., Spackman, K., James, A., Cocos, C., & Boeker, M. (2011). Scalable representations of diseases in biomedical ontologies. Journal of Biomedical Semantics, 2(Suppl 2), S6. http://doi.org/10.1186/2041-1480-2-S2-S6

Representing the association of an allergen with an allergic disposition (allergy to x) Simply using causative agent. This is incorrect not only from an ontological but also from a clinical standpoint. An allergy propensity to penicillin is not caused by penicillin but rather the realization of the propensity as an allergic reaction is caused by penicillin. Creating a new role to represent the agent that causes the realization of the disposition as a process. Associating the allergen as a causative agent within a role group with a process that is necessary for an allergic disposition to occur. This is the procedure used for the current model for allergic disposition in which the causative agent is role grouped with an after allergic sensitization (disorder) relationship. An allergy to substance X is therefore interpreted as necessarily following a sensitization (immune response to X) which is caused by X. Alternatively, causative agent substance and pathological process allergic process can be grouped in role group 1 and after allergic sensitization added to role group 0 Use has realization allergic reaction in a role group with causative agent substance X

Has realization Potential values Allergic reaction (disorder) Interpreted as a clinical life phase which includes a pathological process Allergic reaction to x Requires precoordination of many Allergic reaction to x concepts that parallel Allergy to x Allergic reaction process (qualifier value)

Has realization – comparison of models

Has realization - recommendation Use has realization allergic reaction process (qualifier value) in a role group with causative agent substance to represent the association of an allergen with an allergic disposition Process is the approved range for has realization in the observables model. This model is applicable to any disposition associated with a material agent unlike the current model for allergic disposition which is applicable only to allergy.

Remaining issues with allergy model Can the top level nodes, hypersensitivity condition, allergic condition, pseudoallergic condition which are essentially disjunctions be fully defined and if so is it appropriate to define using the pathological process role which would then be inherited by the corresponding disposition? What about allergic disorders that are also disjunctive, representing either dispositions or processes (reactions) ? Recommendation is to create parallel concepts of propensity to allergic disorder (caused by X) and allergic disorder (caused by x)